BlackRock
ESLA icon

BlackRock’s Estrella Immunopharma ESLA Stock Holding History

BlackRock’s Portfolio ESLA Stock Details ESLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.7K Buy
52,869
+836
+2% +$597 ﹤0.01% 5442
2026
Q2 		$54.1K Buy
52,033
+12,143
+30% +$15.9K ﹤0.01% 5155
2026
Q1 		$42.3K Buy
39,890
+13,420
+51% +$15.4K ﹤0.01% 5165
2025
Q4 		$41.3K Buy
26,470
+2,386
+10% +$4.52K ﹤0.01% 5092
2025
Q3 		$27.7K Sell
24,084
-7,323
-23% -$7.03K ﹤0.01% 5090
2025
Q2 		$30.2K Buy
31,407
+6,754
+27% +$6.55K ﹤0.01% 5078
2025
Q1 		$22.9K Sell
24,653
-465
-2% -$512 ﹤0.01% 5074
2024
Q4 		$30.1K Buy
25,118
+155
+0.6% +$156 ﹤0.01% 5042
2024
Q3 		$29K Buy
24,963
+17,395
+230% +$22.4K ﹤0.01% 4896
2024
Q2 		$7.95K Buy
+7,568
New +$7.74K ﹤0.01% 5090

Other funds holding ESLA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

BlackRock's ESLA Position: Q3 2026 in Review

BlackRock increased its Estrella Immunopharma (ESLA) stake by 1.6% in Q3 2026, buying an estimated $597 and bringing the position to 52,869 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5442.

BlackRock first reported a position in ESLA in Q2 2024 and has held it in 10 quarters since. The position peaked at $54.1K in Q2 2026. 11 funds tracked by Wall St. Rank hold ESLA as of Q3 2026.

  • BlackRock held 52,869 shares of Estrella Immunopharma worth $24.7K as of Q3 2026.
  • BlackRock bought 836 Estrella Immunopharma shares in Q3 2026, an estimated $597.
  • Estrella Immunopharma made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #5442 holding.
  • BlackRock first reported a position in Estrella Immunopharma in Q2 2024 and has held it in 10 quarters since.
  • BlackRock's Estrella Immunopharma position peaked at $54.1K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.